Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1831005
Max Phase: Preclinical
Molecular Formula: C24H29ClN4
Molecular Weight: 372.52
Molecule Type: Small molecule
Associated Items:
ID: ALA1831005
Max Phase: Preclinical
Molecular Formula: C24H29ClN4
Molecular Weight: 372.52
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CN(C)CCCNCc1nccc2c3ccccc3n(Cc3ccccc3)c12.Cl
Standard InChI: InChI=1S/C24H28N4.ClH/c1-27(2)16-8-14-25-17-22-24-21(13-15-26-22)20-11-6-7-12-23(20)28(24)18-19-9-4-3-5-10-19;/h3-7,9-13,15,25H,8,14,16-18H2,1-2H3;1H
Standard InChI Key: JPENEXDASAMASU-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 372.52 | Molecular Weight (Monoisotopic): 372.2314 | AlogP: 4.28 | #Rotatable Bonds: 8 |
Polar Surface Area: 33.09 | Molecular Species: BASE | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 9.48 | CX LogP: 3.54 | CX LogD: 1.38 |
Aromatic Rings: 4 | Heavy Atoms: 28 | QED Weighted: 0.47 | Np Likeness Score: -0.81 |
1. Chen Z, Cao R, Shi B, Guo L, Sun J, Ma Q, Fan W, Song H.. (2011) Synthesis and biological evaluation of 1,9-disubstituted β-carbolines as potent DNA intercalating and cytotoxic agents., 46 (10): [PMID:21875764] [10.1016/j.ejmech.2011.08.027] |
Source(1):